8 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 8 of 8 clinical reviews.
A complete MD/PharmD-level guide to cholesterol absorption inhibitors: mechanism, clinical evidence, prescribing practice, billing codes, and prior-authorization strategy for ezetimibe and related agents.
A comprehensive clinical monograph on the cholesterol absorption inhibitor drug class, covering ezetimibe pharmacology, trial evidence from IMPROVE-IT and SHARP, prescribing guidance, and combination strategies for LDL-C reduction.
A prescriber-level review of ezetimibe and the cholesterol absorption inhibitor class, including a full drug-drug interaction table, pharmacokinetics, clinical trial data, and dosing guidance.
A board-reviewed, MD/PharmD-level guide to the cholesterol absorption inhibitor drug class, covering ezetimibe pharmacology, clinical trial data, prescribing indications, and the full monitoring bundle for safe long-term use.
Evidence-based titration and tapering protocols for cholesterol absorption inhibitors (ezetimibe class), including step-therapy sequencing, combination stacking, and discontinuation guidance for prescribers.
A clinician-level guide to ezetimibe class adverse events, drug interactions, and monitoring protocols for cholesterol absorption inhibitors used as statin add-on therapy.
A prescriber-level review of cholesterol absorption inhibitors, focusing on ezetimibe and emerging agents, with evidence-based guidance on when and how to add them to statin or non-statin regimens.
A prescriber-level review of ezetimibe and cholesterol absorption inhibitors across special populations, including pregnancy, renal impairment, hepatic disease, pediatric patients, and the elderly. Covers dosing, contraindications, key trial data, and guideline-based recommendations.